166 related articles for article (PubMed ID: 37148598)
1. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis.
Wang Z; Zou Z; Xiao J; Min W; Nan LP; Yuan C; Yuan L; Yang C; Huang R; He Y
Gen Hosp Psychiatry; 2023; 83():86-92. PubMed ID: 37148598
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: A systematic review and meta-analysis.
Luan S; Zhou B; Wu Q; Wan H; Li H
Asian J Psychiatr; 2020 Jun; 51():101983. PubMed ID: 32146142
[TBL] [Abstract][Full Text] [Related]
3. BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis.
Pelosof R; Santos LAD; Farhat LC; Gattaz WF; Talib L; Brunoni AR
World J Biol Psychiatry; 2023 Jan; 24(1):24-33. PubMed ID: 35332840
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia-A Systematic Review and Meta-Analysis.
Szota AM; Kowalewska B; Ćwiklińska-Jurkowska M; Dróżdż W
J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685795
[TBL] [Abstract][Full Text] [Related]
5. BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis.
Brunoni AR; Baeken C; Machado-Vieira R; Gattaz WF; Vanderhasselt MA
World J Biol Psychiatry; 2014 Jul; 15(5):411-8. PubMed ID: 24628093
[TBL] [Abstract][Full Text] [Related]
6. Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study.
Rocha RB; Dondossola ER; Grande AJ; Colonetti T; Ceretta LB; Passos IC; Quevedo J; da Rosa MI
J Psychiatr Res; 2016 Dec; 83():47-53. PubMed ID: 27552533
[TBL] [Abstract][Full Text] [Related]
7. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of a session of electroconvulsive therapy on brain-derived neurotrophic factor plasma levels.
Bioque M; Mac-Dowell KS; Font C; Meseguer A; Macau E; Garcia-Orellana M; Valentí M; Leza JC; Bernardo M
Span J Psychiatry Ment Health; 2023; 16(3):137-142. PubMed ID: 32674992
[TBL] [Abstract][Full Text] [Related]
9. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
10. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
[TBL] [Abstract][Full Text] [Related]
11. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
Kranaster L; Hellweg R; Sartorius A
Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
[TBL] [Abstract][Full Text] [Related]
12. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.
Gedge L; Beaudoin A; Lazowski L; du Toit R; Jokic R; Milev R
Front Psychiatry; 2012; 3():12. PubMed ID: 22375129
[TBL] [Abstract][Full Text] [Related]
13. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
[TBL] [Abstract][Full Text] [Related]
14. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
Freire TF; Fleck MP; da Rocha NS
Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
[TBL] [Abstract][Full Text] [Related]
15. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
[TBL] [Abstract][Full Text] [Related]
18. Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT).
Shahin O; Gohar SM; Ibrahim W; El-Makawi SM; Fakher W; Taher DB; Abdel Samie M; Khalil MA; Saleh AA
Int J Psychiatry Clin Pract; 2022 Nov; 26(4):370-375. PubMed ID: 35192426
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum levels of brain-derived neurotrophic factor with electroconvulsive therapy and pharmacotherapy and its clinical correlates in male schizophrenia patients.
Akbas I; Balaban OD
Acta Neuropsychiatr; 2022 Apr; 34(2):99-105. PubMed ID: 34924073
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
